CCL genes in multiple sclerosis and systemic lupus erythematosus
Tamara Vyshkina1, Andrew Sylvester, Saud Sadiq
1VAMC Research, 800. Irving Avenue, Syracuse, NY 13210, United States.
Journal of Neuroimmunology
|July 8, 2008
Summary
This study investigated CC chemokine ligands (CCLs) in multiple sclerosis (MS) and systemic lupus erythematosus (SLE). While borderline MS associations were rejected, CCL8 showed differential distribution in severe MS, and CCL14 was strongly linked to SLE.
Area of Science:
- Immunogenetics
- Autoimmune Diseases
- Molecular Biology
Background:
- Multiple sclerosis (MS) and systemic lupus erythematosus (SLE) are complex autoimmune disorders with poorly understood genetic underpinnings.
- Candidate gene approaches are crucial for identifying genetic risk factors in autoimmune diseases.
- CC chemokine ligands (CCLs) have been implicated as potential genetic contributors to autoimmune conditions.
Purpose of the Study:
- To refine the role of candidate CC chemokine ligand (CCL) genes in multiple sclerosis (MS).
- To investigate the association of CCL markers with systemic lupus erythematosus (SLE).
- To identify specific CCL variants associated with disease severity in MS and susceptibility in SLE.
Main Methods:
- Statistical analysis of genetic markers and haplotypes in MS and SLE patient cohorts.
- Rigorous correction for multiple testing to assess the significance of genetic associations.
- Stratification of MS patients into severity subgroups to identify differential genetic distributions.
Main Results:
- Previously suggested borderline associations between CCLs and MS were rejected after stringent statistical correction.
- A significant differential distribution of CCL8 marker alleles and a specific haplotype was observed in extreme severity subgroups of MS.
- Strong associations were found between a marker and a haplotype near the CCL14 gene in patients with SLE, suggesting a potential lupus-associated variant.
Conclusions:
- The study refutes previous borderline associations of CCLs with MS but highlights CCL8's potential role in MS severity.
- CCL14 is identified as a strong candidate gene associated with systemic lupus erythematosus (SLE).
- These findings suggest specific CCL genes as potential genetic factors influencing the pathogenesis and clinical presentation of MS and SLE.
Related Concept Videos
01:19Multiple Sclerosis l: Introduction
Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
01:24T Cell Types and Functions
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...